Century Therapeutics, Inc. (IPSC)
NASDAQ: IPSC · Real-Time Price · USD
2.200
-0.050 (-2.22%)
At close: Apr 28, 2026, 4:00 PM EDT
2.160
-0.040 (-1.82%)
After-hours: Apr 28, 2026, 6:30 PM EDT

Century Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2019
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2019
Market Capitalization
3968786199303867
Upgrade
Market Cap Growth
1028.91%1.14%-56.77%-34.34%-65.09%-
Upgrade
Enterprise Value
323-1-5877-6597
Upgrade
Last Close Price
2.200.991.013.325.1315.86
Upgrade
PS Ratio
3.630.8013.0388.8858.19-
Upgrade
PB Ratio
1.210.550.531.081.002.19
Upgrade
P/TBV Ratio
3.180.700.681.081.002.19
Upgrade
P/OCF Ratio
----21.53-
Upgrade
EV/Sales Ratio
2.95--34.33--
Upgrade
Debt / Equity Ratio
0.270.270.330.260.160.06
Upgrade
Debt / EBITDA Ratio
5.795.79----
Upgrade
Net Debt / Equity Ratio
-0.46-0.46-0.84-0.67-0.88-0.50
Upgrade
Net Debt / EBITDA Ratio
37.9337.931.111.112.312.17
Upgrade
Net Debt / FCF Ratio
0.700.701.231.2216.081.48
Upgrade
Asset Turnover
0.380.380.020.010.01-
Upgrade
Quick Ratio
5.825.821.479.8110.6114.25
Upgrade
Current Ratio
5.975.971.509.9210.7214.57
Upgrade
Return on Equity (ROE)
-5.98%-5.98%-73.14%-56.07%-37.46%-40.81%
Upgrade
Return on Assets (ROA)
-3.26%-3.26%-23.67%-18.47%-16.75%-21.80%
Upgrade
Return on Capital Employed (ROCE)
-7.40%-7.40%-60.50%-36.50%-27.10%-22.50%
Upgrade
Earnings Yield
-2.42%-11.03%-147.38%-68.80%-43.28%-11.06%
Upgrade
FCF Yield
-26.44%-120.57%-128.42%-51.39%-5.47%-15.46%
Upgrade
Buyback Yield / Dilution
-10.05%-10.05%-32.60%-2.70%-78.30%-332.95%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.